Author

N. Cebron

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

A. Coggon· 1 shared A. Servat· 1 shared B. Gausseres· 1 shared C. Foret-Lucas· 1 shared C. Trumel· 1 shared E. Monchatre-Leroy· 1 shared E. Picard-Meyer· 1 shared F. Boue· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Coggon

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Intranasal type I interferon treatment is beneficial only when administered before clinical signs onset in the SARS-CoV-2 hamster model

P. Bessiere, M. Wasniewsk, E. Picard-Meyer, A. Servat, T. Figueroa, C. Foret-Lucas, A. Coggon, S. Lesellier, F. Boue, N. Cebron, B. Gausseres, C. Trumel, G. Foucras, F. J. Salguero, E. Monchatre-Leroy, R. Volmer

This study shows that intranasal type I interferon treatment is effective only when given before clinical signs onset in a SARS-CoV-2 hamster model, not after symptoms appear.

bioRxiv · Feb 9, 2021Microbiology